nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—CYP1B1—Erlotinib—kidney cancer	0.213	0.317	CbGbCtD
Procarbazine—CYP1B1—Paclitaxel—kidney cancer	0.195	0.29	CbGbCtD
Procarbazine—XDH—Doxorubicin—kidney cancer	0.158	0.236	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—kidney cancer	0.105	0.157	CbGbCtD
Procarbazine—XDH—Purine metabolism—PPAT—kidney cancer	0.00348	0.0772	CbGpPWpGaD
Procarbazine—XDH—Purine metabolism—APRT—kidney cancer	0.00323	0.0718	CbGpPWpGaD
Procarbazine—XDH—Nucleotide metabolism—PPAT—kidney cancer	0.00175	0.0388	CbGpPWpGaD
Procarbazine—XDH—Nucleotide metabolism—APRT—kidney cancer	0.00162	0.0361	CbGpPWpGaD
Procarbazine—CYP1B1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—kidney cancer	0.00162	0.036	CbGpPWpGaD
Procarbazine—CYP1B1—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.00148	0.0328	CbGpPWpGaD
Procarbazine—CYP1B1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—kidney cancer	0.00148	0.0328	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—JUNB—kidney cancer	0.00144	0.0319	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—ALDH1A1—kidney cancer	0.00113	0.0251	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—SOD2—kidney cancer	0.00111	0.0247	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—CYP1A1—kidney cancer	0.0011	0.0244	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—CYP1A1—kidney cancer	0.00105	0.0234	CbGpPWpGaD
Procarbazine—CYP1B1—Melatonin metabolism and effects—ACHE—kidney cancer	0.000959	0.0213	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—GSTM1—kidney cancer	0.000895	0.0199	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen metabolism—CYP1A1—kidney cancer	0.000848	0.0188	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUND—kidney cancer	0.000804	0.0179	CbGpPWpGaD
Procarbazine—CYP1B1—Tamoxifen metabolism—CYP1A1—kidney cancer	0.00075	0.0167	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00074	0.0164	CbGpPWpGaD
Procarbazine—Atenolol—ABCB1—kidney cancer	0.000737	0.346	CrCbGaD
Procarbazine—CYP1B1—Biological oxidations—ACY1—kidney cancer	0.000717	0.0159	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—SCARB1—kidney cancer	0.000697	0.0155	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—PTGS1—kidney cancer	0.00069	0.0153	CbGpPWpGaD
Procarbazine—Ibuprofen—PTGS1—kidney cancer	0.000677	0.318	CrCbGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—JUN—kidney cancer	0.00059	0.0131	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000581	0.0129	CbGpPWpGaD
Procarbazine—CYP1B1—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000579	0.0129	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.000547	0.0122	CbGpPWpGaD
Procarbazine—CYP1B1—Endogenous sterols—POMC—kidney cancer	0.00052	0.0115	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—SOD2—kidney cancer	0.000471	0.0105	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000407	0.00905	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	0.0004	0.00889	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—CYP1A1—kidney cancer	0.0004	0.00889	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	0.0004	0.00889	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—ALDH1A1—kidney cancer	0.000393	0.00873	CbGpPWpGaD
Procarbazine—Ibuprofen—PTGS2—kidney cancer	0.000387	0.182	CrCbGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000375	0.00832	CbGpPWpGaD
Procarbazine—Ibuprofen—ABCB1—kidney cancer	0.000329	0.154	CrCbGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000324	0.00719	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.00032	0.0071	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—RELA—kidney cancer	0.000272	0.00605	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—PTGS2—kidney cancer	0.000265	0.00588	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000262	0.00583	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000246	0.00547	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000245	0.00544	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000241	0.00536	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	0.000238	0.00529	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—GSTT1—kidney cancer	0.000231	0.00513	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ACY1—kidney cancer	0.000229	0.00508	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.000226	0.00501	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	0.000226	0.00501	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000223	0.00495	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	0.000221	0.0049	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—PTGS1—kidney cancer	0.000216	0.0048	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	0.000215	0.00477	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000196	0.00435	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PDHB—kidney cancer	0.000195	0.00432	CbGpPWpGaD
Procarbazine—Diarrhoea—Erlotinib—kidney cancer	0.000192	0.000681	CcSEcCtD
Procarbazine—Hypotension—Vincristine—kidney cancer	0.000192	0.000681	CcSEcCtD
Procarbazine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000191	0.000677	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000191	0.00424	CbGpPWpGaD
Procarbazine—Feeling abnormal—Dactinomycin—kidney cancer	0.00019	0.000672	CcSEcCtD
Procarbazine—Haemoglobin—Capecitabine—kidney cancer	0.00019	0.000672	CcSEcCtD
Procarbazine—Haemorrhage—Capecitabine—kidney cancer	0.000189	0.000668	CcSEcCtD
Procarbazine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000189	0.000668	CcSEcCtD
Procarbazine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000188	0.000667	CcSEcCtD
Procarbazine—Tremor—Paclitaxel—kidney cancer	0.000188	0.000664	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	0.000188	0.00417	CbGpPWpGaD
Procarbazine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000188	0.000664	CcSEcCtD
Procarbazine—Hypersensitivity—Sorafenib—kidney cancer	0.000186	0.00066	CcSEcCtD
Procarbazine—Insomnia—Vincristine—kidney cancer	0.000186	0.000659	CcSEcCtD
Procarbazine—Anorexia—Gemcitabine—kidney cancer	0.000186	0.000659	CcSEcCtD
Procarbazine—Vomiting—Vinblastine—kidney cancer	0.000186	0.000658	CcSEcCtD
Procarbazine—Dizziness—Erlotinib—kidney cancer	0.000186	0.000658	CcSEcCtD
Procarbazine—Vomiting—Everolimus—kidney cancer	0.000185	0.000656	CcSEcCtD
Procarbazine—Anaemia—Paclitaxel—kidney cancer	0.000185	0.000655	CcSEcCtD
Procarbazine—Paraesthesia—Vincristine—kidney cancer	0.000185	0.000654	CcSEcCtD
Procarbazine—Rash—Everolimus—kidney cancer	0.000184	0.00065	CcSEcCtD
Procarbazine—Dermatitis—Everolimus—kidney cancer	0.000184	0.00065	CcSEcCtD
Procarbazine—Headache—Vinblastine—kidney cancer	0.000183	0.000649	CcSEcCtD
Procarbazine—XDH—Metabolism—CCBL1—kidney cancer	0.000183	0.00406	CbGpPWpGaD
Procarbazine—Purpura—Doxorubicin—kidney cancer	0.000183	0.000646	CcSEcCtD
Procarbazine—Headache—Everolimus—kidney cancer	0.000182	0.000646	CcSEcCtD
Procarbazine—Hypotension—Gemcitabine—kidney cancer	0.000182	0.000646	CcSEcCtD
Procarbazine—Body temperature increased—Dactinomycin—kidney cancer	0.000182	0.000645	CcSEcCtD
Procarbazine—Abdominal pain—Dactinomycin—kidney cancer	0.000182	0.000645	CcSEcCtD
Procarbazine—Asthenia—Sorafenib—kidney cancer	0.000181	0.000642	CcSEcCtD
Procarbazine—Syncope—Paclitaxel—kidney cancer	0.00018	0.000636	CcSEcCtD
Procarbazine—Lethargy—Doxorubicin—kidney cancer	0.00018	0.000636	CcSEcCtD
Procarbazine—Leukopenia—Paclitaxel—kidney cancer	0.000179	0.000635	CcSEcCtD
Procarbazine—Hypersensitivity—Sunitinib—kidney cancer	0.000179	0.000635	CcSEcCtD
Procarbazine—Decreased appetite—Vincristine—kidney cancer	0.000179	0.000633	CcSEcCtD
Procarbazine—Pruritus—Sorafenib—kidney cancer	0.000179	0.000633	CcSEcCtD
Procarbazine—Vomiting—Erlotinib—kidney cancer	0.000179	0.000633	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000178	0.00063	CcSEcCtD
Procarbazine—Fatigue—Vincristine—kidney cancer	0.000177	0.000628	CcSEcCtD
Procarbazine—Rash—Erlotinib—kidney cancer	0.000177	0.000627	CcSEcCtD
Procarbazine—Dermatitis—Erlotinib—kidney cancer	0.000177	0.000627	CcSEcCtD
Procarbazine—Insomnia—Gemcitabine—kidney cancer	0.000177	0.000625	CcSEcCtD
Procarbazine—Headache—Erlotinib—kidney cancer	0.000176	0.000623	CcSEcCtD
Procarbazine—Loss of consciousness—Paclitaxel—kidney cancer	0.000176	0.000623	CcSEcCtD
Procarbazine—Pain—Vincristine—kidney cancer	0.000176	0.000623	CcSEcCtD
Procarbazine—Constipation—Vincristine—kidney cancer	0.000176	0.000623	CcSEcCtD
Procarbazine—Diplopia—Doxorubicin—kidney cancer	0.000176	0.000623	CcSEcCtD
Procarbazine—Paraesthesia—Gemcitabine—kidney cancer	0.000175	0.000621	CcSEcCtD
Procarbazine—Flushing—Capecitabine—kidney cancer	0.000175	0.00062	CcSEcCtD
Procarbazine—Cough—Paclitaxel—kidney cancer	0.000175	0.000619	CcSEcCtD
Procarbazine—Asthenia—Sunitinib—kidney cancer	0.000175	0.000618	CcSEcCtD
Procarbazine—Nausea—Vinblastine—kidney cancer	0.000174	0.000615	CcSEcCtD
Procarbazine—Somnolence—Gemcitabine—kidney cancer	0.000174	0.000614	CcSEcCtD
Procarbazine—Convulsion—Paclitaxel—kidney cancer	0.000174	0.000614	CcSEcCtD
Procarbazine—Nausea—Everolimus—kidney cancer	0.000173	0.000613	CcSEcCtD
Procarbazine—Diarrhoea—Sorafenib—kidney cancer	0.000173	0.000613	CcSEcCtD
Procarbazine—Hypertension—Paclitaxel—kidney cancer	0.000173	0.000612	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—MYC—kidney cancer	0.000173	0.00383	CbGpPWpGaD
Procarbazine—Pruritus—Sunitinib—kidney cancer	0.000172	0.000609	CcSEcCtD
Procarbazine—Arthralgia—Paclitaxel—kidney cancer	0.000171	0.000604	CcSEcCtD
Procarbazine—Myalgia—Paclitaxel—kidney cancer	0.000171	0.000604	CcSEcCtD
Procarbazine—Anxiety—Paclitaxel—kidney cancer	0.00017	0.000602	CcSEcCtD
Procarbazine—Decreased appetite—Gemcitabine—kidney cancer	0.00017	0.000601	CcSEcCtD
Procarbazine—Hypersensitivity—Dactinomycin—kidney cancer	0.00017	0.000601	CcSEcCtD
Procarbazine—Chills—Capecitabine—kidney cancer	0.000169	0.0006	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	0.000169	0.00375	CbGpPWpGaD
Procarbazine—Arrhythmia—Capecitabine—kidney cancer	0.000169	0.000597	CcSEcCtD
Procarbazine—Fatigue—Gemcitabine—kidney cancer	0.000168	0.000596	CcSEcCtD
Procarbazine—Gastrointestinal pain—Vincristine—kidney cancer	0.000168	0.000596	CcSEcCtD
Procarbazine—Dizziness—Sorafenib—kidney cancer	0.000167	0.000592	CcSEcCtD
Procarbazine—Pain—Gemcitabine—kidney cancer	0.000167	0.000591	CcSEcCtD
Procarbazine—Constipation—Gemcitabine—kidney cancer	0.000167	0.000591	CcSEcCtD
Procarbazine—Nausea—Erlotinib—kidney cancer	0.000167	0.000591	CcSEcCtD
Procarbazine—Alopecia—Capecitabine—kidney cancer	0.000167	0.000591	CcSEcCtD
Procarbazine—Dry mouth—Paclitaxel—kidney cancer	0.000167	0.00059	CcSEcCtD
Procarbazine—Diarrhoea—Sunitinib—kidney cancer	0.000166	0.000589	CcSEcCtD
Procarbazine—Ataxia—Doxorubicin—kidney cancer	0.000165	0.000586	CcSEcCtD
Procarbazine—Asthenia—Dactinomycin—kidney cancer	0.000165	0.000585	CcSEcCtD
Procarbazine—Confusional state—Paclitaxel—kidney cancer	0.000165	0.000584	CcSEcCtD
Procarbazine—Oedema—Paclitaxel—kidney cancer	0.000163	0.000579	CcSEcCtD
Procarbazine—Abdominal pain—Vincristine—kidney cancer	0.000163	0.000576	CcSEcCtD
Procarbazine—Body temperature increased—Vincristine—kidney cancer	0.000163	0.000576	CcSEcCtD
Procarbazine—Infection—Paclitaxel—kidney cancer	0.000162	0.000575	CcSEcCtD
Procarbazine—Dizziness—Sunitinib—kidney cancer	0.000161	0.00057	CcSEcCtD
Procarbazine—Feeling abnormal—Gemcitabine—kidney cancer	0.000161	0.00057	CcSEcCtD
Procarbazine—Shock—Paclitaxel—kidney cancer	0.000161	0.000569	CcSEcCtD
Procarbazine—Vomiting—Sorafenib—kidney cancer	0.000161	0.000569	CcSEcCtD
Procarbazine—Thrombocytopenia—Paclitaxel—kidney cancer	0.00016	0.000567	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTP1—kidney cancer	0.00016	0.00355	CbGpPWpGaD
Procarbazine—Tachycardia—Paclitaxel—kidney cancer	0.00016	0.000565	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	0.000159	0.00354	CbGpPWpGaD
Procarbazine—Rash—Sorafenib—kidney cancer	0.000159	0.000564	CcSEcCtD
Procarbazine—Dermatitis—Sorafenib—kidney cancer	0.000159	0.000564	CcSEcCtD
Procarbazine—XDH—Metabolism—GLIPR1—kidney cancer	0.000159	0.00352	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PPAT—kidney cancer	0.000159	0.00352	CbGpPWpGaD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000158	0.000561	CcSEcCtD
Procarbazine—Headache—Sorafenib—kidney cancer	0.000158	0.000561	CcSEcCtD
Procarbazine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000158	0.000559	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTP1—kidney cancer	0.000158	0.00351	CbGpPWpGaD
Procarbazine—Diarrhoea—Dactinomycin—kidney cancer	0.000158	0.000558	CcSEcCtD
Procarbazine—Anorexia—Paclitaxel—kidney cancer	0.000156	0.000552	CcSEcCtD
Procarbazine—Vomiting—Sunitinib—kidney cancer	0.000155	0.000548	CcSEcCtD
Procarbazine—Body temperature increased—Gemcitabine—kidney cancer	0.000154	0.000546	CcSEcCtD
Procarbazine—Tremor—Capecitabine—kidney cancer	0.000154	0.000545	CcSEcCtD
Procarbazine—Rash—Sunitinib—kidney cancer	0.000153	0.000543	CcSEcCtD
Procarbazine—Dermatitis—Sunitinib—kidney cancer	0.000153	0.000543	CcSEcCtD
Procarbazine—Hypotension—Paclitaxel—kidney cancer	0.000153	0.000541	CcSEcCtD
Procarbazine—Headache—Sunitinib—kidney cancer	0.000152	0.00054	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—kidney cancer	0.000152	0.000538	CcSEcCtD
Procarbazine—Anaemia—Capecitabine—kidney cancer	0.000152	0.000538	CcSEcCtD
Procarbazine—Hypersensitivity—Vincristine—kidney cancer	0.000152	0.000537	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—kidney cancer	0.000151	0.000533	CcSEcCtD
Procarbazine—Nausea—Sorafenib—kidney cancer	0.00015	0.000532	CcSEcCtD
Procarbazine—Pancreatitis—Doxorubicin—kidney cancer	0.000149	0.000528	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000149	0.000527	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—kidney cancer	0.000148	0.000524	CcSEcCtD
Procarbazine—Insomnia—Paclitaxel—kidney cancer	0.000148	0.000523	CcSEcCtD
Procarbazine—Asthenia—Vincristine—kidney cancer	0.000148	0.000523	CcSEcCtD
Procarbazine—XDH—Metabolism—APRT—kidney cancer	0.000148	0.00328	CbGpPWpGaD
Procarbazine—XDH—Metabolism—FH—kidney cancer	0.000148	0.00328	CbGpPWpGaD
Procarbazine—Syncope—Capecitabine—kidney cancer	0.000147	0.000522	CcSEcCtD
Procarbazine—Leukopenia—Capecitabine—kidney cancer	0.000147	0.000521	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—GSTM1—kidney cancer	0.000147	0.00327	CbGpPWpGaD
Procarbazine—Paraesthesia—Paclitaxel—kidney cancer	0.000147	0.00052	CcSEcCtD
Procarbazine—Vomiting—Dactinomycin—kidney cancer	0.000146	0.000519	CcSEcCtD
Procarbazine—Somnolence—Paclitaxel—kidney cancer	0.000145	0.000514	CcSEcCtD
Procarbazine—Rash—Dactinomycin—kidney cancer	0.000145	0.000514	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—GSTM1—kidney cancer	0.000145	0.00322	CbGpPWpGaD
Procarbazine—Nausea—Sunitinib—kidney cancer	0.000145	0.000512	CcSEcCtD
Procarbazine—Loss of consciousness—Capecitabine—kidney cancer	0.000144	0.000511	CcSEcCtD
Procarbazine—Pancytopenia—Doxorubicin—kidney cancer	0.000144	0.000511	CcSEcCtD
Procarbazine—Cough—Capecitabine—kidney cancer	0.000143	0.000508	CcSEcCtD
Procarbazine—Decreased appetite—Paclitaxel—kidney cancer	0.000142	0.000503	CcSEcCtD
Procarbazine—Hypertension—Capecitabine—kidney cancer	0.000142	0.000502	CcSEcCtD
Procarbazine—Fatigue—Paclitaxel—kidney cancer	0.000141	0.000499	CcSEcCtD
Procarbazine—Diarrhoea—Vincristine—kidney cancer	0.000141	0.000499	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—kidney cancer	0.00014	0.000497	CcSEcCtD
Procarbazine—Asthenia—Gemcitabine—kidney cancer	0.00014	0.000496	CcSEcCtD
Procarbazine—Myalgia—Capecitabine—kidney cancer	0.00014	0.000495	CcSEcCtD
Procarbazine—Arthralgia—Capecitabine—kidney cancer	0.00014	0.000495	CcSEcCtD
Procarbazine—Constipation—Paclitaxel—kidney cancer	0.00014	0.000495	CcSEcCtD
Procarbazine—Pain—Paclitaxel—kidney cancer	0.00014	0.000495	CcSEcCtD
Procarbazine—Anxiety—Capecitabine—kidney cancer	0.000139	0.000494	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—CYP1A1—kidney cancer	0.000139	0.0031	CbGpPWpGaD
Procarbazine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000139	0.000491	CcSEcCtD
Procarbazine—XDH—Metabolism—GPC3—kidney cancer	0.000139	0.00308	CbGpPWpGaD
Procarbazine—Pruritus—Gemcitabine—kidney cancer	0.000138	0.000489	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000138	0.00305	CbGpPWpGaD
Procarbazine—Dry mouth—Capecitabine—kidney cancer	0.000137	0.000485	CcSEcCtD
Procarbazine—Nausea—Dactinomycin—kidney cancer	0.000137	0.000484	CcSEcCtD
Procarbazine—Pneumonia—Doxorubicin—kidney cancer	0.000136	0.000483	CcSEcCtD
Procarbazine—Dizziness—Vincristine—kidney cancer	0.000136	0.000482	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—kidney cancer	0.000136	0.00048	CcSEcCtD
Procarbazine—Confusional state—Capecitabine—kidney cancer	0.000135	0.000479	CcSEcCtD
Procarbazine—XDH—Metabolism—CA2—kidney cancer	0.000135	0.003	CbGpPWpGaD
Procarbazine—Feeling abnormal—Paclitaxel—kidney cancer	0.000135	0.000477	CcSEcCtD
Procarbazine—Oedema—Capecitabine—kidney cancer	0.000134	0.000475	CcSEcCtD
Procarbazine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000134	0.000473	CcSEcCtD
Procarbazine—Diarrhoea—Gemcitabine—kidney cancer	0.000134	0.000473	CcSEcCtD
Procarbazine—Infection—Capecitabine—kidney cancer	0.000133	0.000472	CcSEcCtD
Procarbazine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000133	0.00047	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—kidney cancer	0.000132	0.000468	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—kidney cancer	0.000132	0.000468	CcSEcCtD
Procarbazine—Shock—Capecitabine—kidney cancer	0.000132	0.000467	CcSEcCtD
Procarbazine—XDH—Metabolism—ALAD—kidney cancer	0.000131	0.00292	CbGpPWpGaD
Procarbazine—Thrombocytopenia—Capecitabine—kidney cancer	0.000131	0.000465	CcSEcCtD
Procarbazine—Tachycardia—Capecitabine—kidney cancer	0.000131	0.000464	CcSEcCtD
Procarbazine—Vomiting—Vincristine—kidney cancer	0.000131	0.000463	CcSEcCtD
Procarbazine—Sweating—Doxorubicin—kidney cancer	0.00013	0.00046	CcSEcCtD
Procarbazine—Urticaria—Paclitaxel—kidney cancer	0.00013	0.00046	CcSEcCtD
Procarbazine—Rash—Vincristine—kidney cancer	0.00013	0.000459	CcSEcCtD
Procarbazine—Hyperhidrosis—Capecitabine—kidney cancer	0.00013	0.000459	CcSEcCtD
Procarbazine—Dermatitis—Vincristine—kidney cancer	0.00013	0.000459	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—kidney cancer	0.000129	0.000458	CcSEcCtD
Procarbazine—Body temperature increased—Paclitaxel—kidney cancer	0.000129	0.000457	CcSEcCtD
Procarbazine—Abdominal pain—Paclitaxel—kidney cancer	0.000129	0.000457	CcSEcCtD
Procarbazine—Headache—Vincristine—kidney cancer	0.000129	0.000456	CcSEcCtD
Procarbazine—XDH—Metabolism—ST3GAL2—kidney cancer	0.000128	0.00285	CbGpPWpGaD
Procarbazine—Epistaxis—Doxorubicin—kidney cancer	0.000128	0.000453	CcSEcCtD
Procarbazine—Anorexia—Capecitabine—kidney cancer	0.000128	0.000453	CcSEcCtD
Procarbazine—XDH—Metabolism—ALDH1A1—kidney cancer	0.000125	0.00279	CbGpPWpGaD
Procarbazine—Hypotension—Capecitabine—kidney cancer	0.000125	0.000444	CcSEcCtD
Procarbazine—Vomiting—Gemcitabine—kidney cancer	0.000124	0.000439	CcSEcCtD
Procarbazine—Rash—Gemcitabine—kidney cancer	0.000123	0.000436	CcSEcCtD
Procarbazine—Dermatitis—Gemcitabine—kidney cancer	0.000123	0.000435	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—ACY1—kidney cancer	0.000123	0.00272	CbGpPWpGaD
Procarbazine—Haemoglobin—Doxorubicin—kidney cancer	0.000122	0.000433	CcSEcCtD
Procarbazine—Headache—Gemcitabine—kidney cancer	0.000122	0.000433	CcSEcCtD
Procarbazine—Nausea—Vincristine—kidney cancer	0.000122	0.000433	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000122	0.000433	CcSEcCtD
Procarbazine—Haemorrhage—Doxorubicin—kidney cancer	0.000122	0.000431	CcSEcCtD
Procarbazine—Insomnia—Capecitabine—kidney cancer	0.000121	0.00043	CcSEcCtD
Procarbazine—Paraesthesia—Capecitabine—kidney cancer	0.00012	0.000426	CcSEcCtD
Procarbazine—Hypersensitivity—Paclitaxel—kidney cancer	0.00012	0.000426	CcSEcCtD
Procarbazine—XDH—Metabolism—PGK1—kidney cancer	0.00012	0.00267	CbGpPWpGaD
Procarbazine—XDH—Metabolism—SLC5A3—kidney cancer	0.00012	0.00267	CbGpPWpGaD
Procarbazine—XDH—Metabolism—LDHB—kidney cancer	0.000118	0.00262	CbGpPWpGaD
Procarbazine—Asthenia—Paclitaxel—kidney cancer	0.000117	0.000415	CcSEcCtD
Procarbazine—Decreased appetite—Capecitabine—kidney cancer	0.000117	0.000413	CcSEcCtD
Procarbazine—Nausea—Gemcitabine—kidney cancer	0.000116	0.000411	CcSEcCtD
Procarbazine—Fatigue—Capecitabine—kidney cancer	0.000116	0.000409	CcSEcCtD
Procarbazine—Pruritus—Paclitaxel—kidney cancer	0.000116	0.000409	CcSEcCtD
Procarbazine—Pain—Capecitabine—kidney cancer	0.000115	0.000406	CcSEcCtD
Procarbazine—Constipation—Capecitabine—kidney cancer	0.000115	0.000406	CcSEcCtD
Procarbazine—Flushing—Doxorubicin—kidney cancer	0.000113	0.0004	CcSEcCtD
Procarbazine—Diarrhoea—Paclitaxel—kidney cancer	0.000112	0.000396	CcSEcCtD
Procarbazine—Feeling abnormal—Capecitabine—kidney cancer	0.000111	0.000391	CcSEcCtD
Procarbazine—Gastrointestinal pain—Capecitabine—kidney cancer	0.00011	0.000388	CcSEcCtD
Procarbazine—Chills—Doxorubicin—kidney cancer	0.000109	0.000387	CcSEcCtD
Procarbazine—Arrhythmia—Doxorubicin—kidney cancer	0.000109	0.000385	CcSEcCtD
Procarbazine—Dizziness—Paclitaxel—kidney cancer	0.000108	0.000383	CcSEcCtD
Procarbazine—Alopecia—Doxorubicin—kidney cancer	0.000108	0.000381	CcSEcCtD
Procarbazine—Urticaria—Capecitabine—kidney cancer	0.000107	0.000377	CcSEcCtD
Procarbazine—Abdominal pain—Capecitabine—kidney cancer	0.000106	0.000375	CcSEcCtD
Procarbazine—Body temperature increased—Capecitabine—kidney cancer	0.000106	0.000375	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000105	0.00232	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PDHB—kidney cancer	0.000104	0.00232	CbGpPWpGaD
Procarbazine—Tension—Doxorubicin—kidney cancer	0.000104	0.000368	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—POMC—kidney cancer	0.000104	0.00231	CbGpPWpGaD
Procarbazine—Vomiting—Paclitaxel—kidney cancer	0.000104	0.000368	CcSEcCtD
Procarbazine—Rash—Paclitaxel—kidney cancer	0.000103	0.000365	CcSEcCtD
Procarbazine—Dermatitis—Paclitaxel—kidney cancer	0.000103	0.000365	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—kidney cancer	0.000103	0.000364	CcSEcCtD
Procarbazine—Headache—Paclitaxel—kidney cancer	0.000102	0.000363	CcSEcCtD
Procarbazine—XDH—Metabolism—CA9—kidney cancer	0.000102	0.00227	CbGpPWpGaD
Procarbazine—Hypersensitivity—Capecitabine—kidney cancer	9.88e-05	0.00035	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—CCBL1—kidney cancer	9.8e-05	0.00218	CbGpPWpGaD
Procarbazine—Anaemia—Doxorubicin—kidney cancer	9.79e-05	0.000347	CcSEcCtD
Procarbazine—Nausea—Paclitaxel—kidney cancer	9.71e-05	0.000344	CcSEcCtD
Procarbazine—Asthenia—Capecitabine—kidney cancer	9.62e-05	0.000341	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—kidney cancer	9.5e-05	0.000336	CcSEcCtD
Procarbazine—Pruritus—Capecitabine—kidney cancer	9.49e-05	0.000336	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—kidney cancer	9.48e-05	0.000336	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—kidney cancer	9.31e-05	0.00033	CcSEcCtD
Procarbazine—Cough—Doxorubicin—kidney cancer	9.25e-05	0.000327	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—kidney cancer	9.18e-05	0.000325	CcSEcCtD
Procarbazine—Diarrhoea—Capecitabine—kidney cancer	9.18e-05	0.000325	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—kidney cancer	9.15e-05	0.000324	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—kidney cancer	9.02e-05	0.000319	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—kidney cancer	9.02e-05	0.000319	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—kidney cancer	8.99e-05	0.000318	CcSEcCtD
Procarbazine—Dizziness—Capecitabine—kidney cancer	8.87e-05	0.000314	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	8.87e-05	0.00197	CbGpPWpGaD
Procarbazine—Dry mouth—Doxorubicin—kidney cancer	8.82e-05	0.000312	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—kidney cancer	8.72e-05	0.000309	CcSEcCtD
Procarbazine—XDH—Metabolism—CRABP1—kidney cancer	8.7e-05	0.00193	CbGpPWpGaD
Procarbazine—Oedema—Doxorubicin—kidney cancer	8.65e-05	0.000306	CcSEcCtD
Procarbazine—Infection—Doxorubicin—kidney cancer	8.59e-05	0.000304	CcSEcCtD
Procarbazine—Vomiting—Capecitabine—kidney cancer	8.53e-05	0.000302	CcSEcCtD
Procarbazine—Shock—Doxorubicin—kidney cancer	8.51e-05	0.000301	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—GLIPR1—kidney cancer	8.5e-05	0.00189	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PPAT—kidney cancer	8.5e-05	0.00189	CbGpPWpGaD
Procarbazine—Thrombocytopenia—Doxorubicin—kidney cancer	8.47e-05	0.0003	CcSEcCtD
Procarbazine—Rash—Capecitabine—kidney cancer	8.46e-05	0.000299	CcSEcCtD
Procarbazine—Dermatitis—Capecitabine—kidney cancer	8.45e-05	0.000299	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—kidney cancer	8.44e-05	0.000299	CcSEcCtD
Procarbazine—Headache—Capecitabine—kidney cancer	8.4e-05	0.000298	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	8.39e-05	0.00186	CbGpPWpGaD
Procarbazine—Hyperhidrosis—Doxorubicin—kidney cancer	8.36e-05	0.000296	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	8.31e-05	0.00185	CbGpPWpGaD
Procarbazine—Anorexia—Doxorubicin—kidney cancer	8.24e-05	0.000292	CcSEcCtD
Procarbazine—XDH—Metabolism—ITPR2—kidney cancer	8.08e-05	0.0018	CbGpPWpGaD
Procarbazine—Hypotension—Doxorubicin—kidney cancer	8.08e-05	0.000286	CcSEcCtD
Procarbazine—Nausea—Capecitabine—kidney cancer	7.97e-05	0.000282	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—FH—kidney cancer	7.9e-05	0.00176	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—APRT—kidney cancer	7.9e-05	0.00176	CbGpPWpGaD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.88e-05	0.000279	CcSEcCtD
Procarbazine—Insomnia—Doxorubicin—kidney cancer	7.82e-05	0.000277	CcSEcCtD
Procarbazine—Paraesthesia—Doxorubicin—kidney cancer	7.76e-05	0.000275	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	7.72e-05	0.00172	CbGpPWpGaD
Procarbazine—Somnolence—Doxorubicin—kidney cancer	7.69e-05	0.000272	CcSEcCtD
Procarbazine—Decreased appetite—Doxorubicin—kidney cancer	7.52e-05	0.000266	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—kidney cancer	7.46e-05	0.000264	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—GPC3—kidney cancer	7.43e-05	0.00165	CbGpPWpGaD
Procarbazine—Pain—Doxorubicin—kidney cancer	7.39e-05	0.000262	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—kidney cancer	7.39e-05	0.000262	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTT1—kidney cancer	7.37e-05	0.00164	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ACHE—kidney cancer	7.37e-05	0.00164	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CA2—kidney cancer	7.23e-05	0.00161	CbGpPWpGaD
Procarbazine—Feeling abnormal—Doxorubicin—kidney cancer	7.13e-05	0.000252	CcSEcCtD
Procarbazine—Gastrointestinal pain—Doxorubicin—kidney cancer	7.07e-05	0.00025	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—ALAD—kidney cancer	7.04e-05	0.00156	CbGpPWpGaD
Procarbazine—XDH—Metabolism—SCARB1—kidney cancer	6.98e-05	0.00155	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PTGS1—kidney cancer	6.91e-05	0.00153	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ST3GAL2—kidney cancer	6.88e-05	0.00153	CbGpPWpGaD
Procarbazine—Urticaria—Doxorubicin—kidney cancer	6.87e-05	0.000243	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—kidney cancer	6.84e-05	0.000242	CcSEcCtD
Procarbazine—Body temperature increased—Doxorubicin—kidney cancer	6.84e-05	0.000242	CcSEcCtD
Procarbazine—XDH—Metabolism—PSMD7—kidney cancer	6.77e-05	0.0015	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ALDH1A1—kidney cancer	6.72e-05	0.00149	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—SLC5A3—kidney cancer	6.44e-05	0.00143	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PGK1—kidney cancer	6.44e-05	0.00143	CbGpPWpGaD
Procarbazine—XDH—Metabolism—BCHE—kidney cancer	6.42e-05	0.00143	CbGpPWpGaD
Procarbazine—Hypersensitivity—Doxorubicin—kidney cancer	6.37e-05	0.000226	CcSEcCtD
Procarbazine—XDH—Metabolism—SLC5A5—kidney cancer	6.34e-05	0.00141	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—LDHB—kidney cancer	6.32e-05	0.0014	CbGpPWpGaD
Procarbazine—Asthenia—Doxorubicin—kidney cancer	6.2e-05	0.00022	CcSEcCtD
Procarbazine—XDH—Metabolism—SLC2A1—kidney cancer	6.13e-05	0.00136	CbGpPWpGaD
Procarbazine—Pruritus—Doxorubicin—kidney cancer	6.12e-05	0.000217	CcSEcCtD
Procarbazine—Diarrhoea—Doxorubicin—kidney cancer	5.92e-05	0.000209	CcSEcCtD
Procarbazine—Dizziness—Doxorubicin—kidney cancer	5.72e-05	0.000202	CcSEcCtD
Procarbazine—Vomiting—Doxorubicin—kidney cancer	5.5e-05	0.000195	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—CA9—kidney cancer	5.48e-05	0.00122	CbGpPWpGaD
Procarbazine—Rash—Doxorubicin—kidney cancer	5.45e-05	0.000193	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—kidney cancer	5.45e-05	0.000193	CcSEcCtD
Procarbazine—Headache—Doxorubicin—kidney cancer	5.42e-05	0.000192	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.35e-05	0.00119	CbGpPWpGaD
Procarbazine—Nausea—Doxorubicin—kidney cancer	5.14e-05	0.000182	CcSEcCtD
Procarbazine—XDH—Metabolism—GSTP1—kidney cancer	5.11e-05	0.00113	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ABCB1—kidney cancer	4.84e-05	0.00107	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GSTM1—kidney cancer	4.7e-05	0.00104	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CRABP1—kidney cancer	4.66e-05	0.00103	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYP1A1—kidney cancer	4.45e-05	0.000989	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ITPR2—kidney cancer	4.33e-05	0.000962	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.99e-05	0.000886	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ACHE—kidney cancer	3.95e-05	0.000877	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTT1—kidney cancer	3.95e-05	0.000877	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—SCARB1—kidney cancer	3.74e-05	0.00083	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PTGS1—kidney cancer	3.7e-05	0.000822	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PSMD7—kidney cancer	3.63e-05	0.000806	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—BCHE—kidney cancer	3.44e-05	0.000764	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—SLC5A5—kidney cancer	3.4e-05	0.000755	CbGpPWpGaD
Procarbazine—XDH—Metabolism—POMC—kidney cancer	3.32e-05	0.000737	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—SLC2A1—kidney cancer	3.28e-05	0.000729	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.18e-05	0.000707	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.78e-05	0.000617	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTP1—kidney cancer	2.74e-05	0.000608	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PTGS2—kidney cancer	2.65e-05	0.000588	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ABCB1—kidney cancer	2.59e-05	0.000575	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GSTM1—kidney cancer	2.52e-05	0.000559	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP1A1—kidney cancer	2.38e-05	0.00053	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PTEN—kidney cancer	2.31e-05	0.000513	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.96e-05	0.000435	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—POMC—kidney cancer	1.78e-05	0.000395	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PIK3CA—kidney cancer	1.63e-05	0.000362	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PTGS2—kidney cancer	1.42e-05	0.000315	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PTEN—kidney cancer	1.24e-05	0.000275	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CA—kidney cancer	8.72e-06	0.000194	CbGpPWpGaD
